APA (7th ed.) Citation

J, B., P, B., & J, S. (2012). Timely 'off-label' use of recombinant activated factor VII (NovoSeven(®)) can help in avoiding hysterectomy in intractable obstetric bleeding complicated with disseminated intravascular coagulation: A case report and review of the literature. Indian journal of anaesthesia, 56(1), 69. https://doi.org/10.4103/0019-5049.93349

Chicago Style (17th ed.) Citation

J, Burad, Bhakta P, and Sharma J. "Timely 'Off-label' Use of Recombinant Activated Factor VII (NovoSeven(®)) Can Help in Avoiding Hysterectomy in Intractable Obstetric Bleeding Complicated with Disseminated Intravascular Coagulation: A Case Report and Review of the Literature." Indian Journal of Anaesthesia 56, no. 1 (2012): 69. https://doi.org/10.4103/0019-5049.93349.

MLA (9th ed.) Citation

J, Burad, et al. "Timely 'Off-label' Use of Recombinant Activated Factor VII (NovoSeven(®)) Can Help in Avoiding Hysterectomy in Intractable Obstetric Bleeding Complicated with Disseminated Intravascular Coagulation: A Case Report and Review of the Literature." Indian Journal of Anaesthesia, vol. 56, no. 1, 2012, p. 69, https://doi.org/10.4103/0019-5049.93349.